Quotient Sciences, a leading global drug development and manufacturing accelerator, and UK technology innovation centre, CPI, have signed a memorandum of understanding (MoU) to form a Joint Venture (JV) aimed at accelerating the development of RNA-based therapies. The JV will combine Quotient Sciences’ Translational Pharmaceutics® platform with CPI’s expertise in small scale manufacture of RNA […]
Post Type Archives: News
LOTTE BIOLOGICS establishes contract manufacturing partnership with a leading U.S. Biopharmaceutical
LOTTE BIOLOGICS (CEO James Park) today announced that it has entered a late-stage to commercial contract manufacturing partnership with a U.S.-based global biopharmaceutical company. The partnership covers a late-stage Phase 3 program that is advancing into multiple new indications, and extends to commercial supply following potential regulatory approvals. By aligning with its partner’s meaningful pipeline […]
CORMEDIX COMPLETES ACQUISITION OF MELINTA THERAPEUTICS, RAISES FINANCIAL GUIDANCE AND ANNOUNCES NEW LEADERSHIP TEAM
CorMedix Inc., a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced that it has successfully completed its previously announced acquisition of Melinta Therapeutics LLC (“Melinta”), a private commercial-stage company providing innovative therapies for acute and life-threatening illnesses. “This acquisition is a transformational step in the evolution of […]
Novo Nordisk’s Wegovy® cuts risk of heart attack, stroke or death by 57% compared to tirzepatide in real-world study of people with obesity and cardiovascular diseas
Novo Nordisk today presented data from the STEER real-world study of evidence gathered from actual patient experiences at the European Society of Cardiology (ESC) Congress 2025 in Madrid, Spain. The STEER study investigated the risk of major adverse cardiovascular events (MACE) with Wegovy® (semaglutide 2.4 mg) compared with tirzepatide treatment in people with overweight or […]
Hongene to supply exNA oligonucleotide technology under new licensing deal
Hongene Biotech Corporation, a contract development and manufacturing organization (CDMO) specializing in nucleic acid therapeutics, today entered a non-exclusive licensing agreement with the UMass Chan Medical School to produce and supply extended nucleic acid (exNA) monomers and exNA-modified oligonucleotides for research use. The agreement strengthens Hongene’s RNA chemistry portfolio and expands access to innovative oligonucleotide […]
AbbVie Completes Acquisition of Capstan Therapeutics
AbbVie announced that it has completed its acquisition of Capstan Therapeutics. With the completion of the acquisition, Capstan is now a part of AbbVie. Capstan’s lead asset CPTX2309, currently in Phase 1 for the treatment of B cell-mediated autoimmune diseases, is a tLNP that generates CD19-specific, CD8+ in vivo CAR-T cells. The CAR-T cells are designed to […]
Camena Bioscience and Constructive Bio join synthetic biology collaboration to develop plant genomics
Camena Bioscience (Camena), an innovator in enzymatic DNA synthesis, and Constructive Bio (Constructive), a pioneer in whole genome writing, today announced they have joined a collaborative project led by the Max-Planck Institute of Molecular Plant Physiology (MPI-MP), Germany, for a research initiative to develop synthetic chloroplast genomes. Until now, constructing synthetic chloroplast genomes has been […]
Veranova’s Devens Site Successfully Passes FDA Inspection with Zero Observations
Veranova, a global leader in the development and manufacture of specialty and complex active pharmaceutical ingredients (API) for the pharmaceutical and biotech sectors, announced today that a routine current Good Manufacturing Practice (cGMP) surveillance inspection of Veranova’s Devens, Massachusetts site, completed by the Food and Drug Administration (FDA) New England District on July 31, 2025, […]
John Bender Joins Woodstock Sterile Solutions, Halo Pharma as VP, Business Development
Bender brings 35 years of pharmaceutical industry experience to dual role Woodstock, IL, August 12, 2025 – Woodstock Sterile Solutions, a leading blow-fill-seal (BFS) contract development and manufacturing organisation (CDMO), and Halo Pharma, a leading CDMO specialising in pharmaceutical services, have named John Bender as the new Vice President of Business Development for the two […]
AbbVie Announces $195 Million Investment to Expand Active Pharmaceutical Ingredient Manufacturing in the U.S.
AbbVie announced a $195 million investment in its North Chicago, Illinois manufacturing plant to expand domestic active pharmaceutical ingredient (API) production in the U.S. This expansion is part of AbbVie’s previously announced commitment to invest more than $10 billion of capital in the U.S. to broadly support innovation and expand critical manufacturing capabilities and capacity. Active pharmaceutical ingredient manufacturing is […]